EE04496B1 - Tetrahüdro-gamma-karboliinid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad kompositsioonid - Google Patents

Tetrahüdro-gamma-karboliinid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad kompositsioonid

Info

Publication number
EE04496B1
EE04496B1 EEP200000059A EEP200000059A EE04496B1 EE 04496 B1 EE04496 B1 EE 04496B1 EE P200000059 A EEP200000059 A EE P200000059A EE P200000059 A EEP200000059 A EE P200000059A EE 04496 B1 EE04496 B1 EE 04496B1
Authority
EE
Estonia
Prior art keywords
optionally substituted
preparation
compositions containing
carbolines
medicaments
Prior art date
Application number
EEP200000059A
Other languages
English (en)
Estonian (et)
Inventor
Edmond Josephine Kennis Ludo
Carolus Mertens Josephus
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200000059A publication Critical patent/EE200000059A/xx
Publication of EE04496B1 publication Critical patent/EE04496B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200000059A 1997-09-08 1998-09-01 Tetrahüdro-gamma-karboliinid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad kompositsioonid EE04496B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202761A EP0905136A1 (en) 1997-09-08 1997-09-08 Tetrahydro gamma-carbolines
PCT/EP1998/005710 WO1999012926A1 (en) 1997-09-08 1998-09-01 Tetrahydro gamma-carbolines

Publications (2)

Publication Number Publication Date
EE200000059A EE200000059A (et) 2000-10-16
EE04496B1 true EE04496B1 (et) 2005-06-15

Family

ID=8228715

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000059A EE04496B1 (et) 1997-09-08 1998-09-01 Tetrahüdro-gamma-karboliinid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad kompositsioonid

Country Status (27)

Country Link
US (2) US6303614B1 (es)
EP (2) EP0905136A1 (es)
JP (1) JP2001515899A (es)
KR (1) KR100603896B1 (es)
CN (1) CN1110496C (es)
AT (1) ATE243209T1 (es)
AU (1) AU752410B2 (es)
BR (1) BR9811769A (es)
CA (1) CA2301807A1 (es)
CZ (1) CZ297220B6 (es)
DE (1) DE69815700T2 (es)
EE (1) EE04496B1 (es)
ES (1) ES2202902T3 (es)
HR (1) HRP20000108A2 (es)
HU (1) HUP0003577A3 (es)
ID (1) ID23954A (es)
IL (1) IL134894A (es)
MY (1) MY129176A (es)
NO (1) NO315236B1 (es)
NZ (1) NZ503096A (es)
PL (1) PL191863B1 (es)
RU (1) RU2208614C2 (es)
SK (1) SK285594B6 (es)
TR (1) TR200000616T2 (es)
TW (1) TW531539B (es)
WO (1) WO1999012926A1 (es)
ZA (1) ZA988161B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG146683A1 (en) 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
UA85563C2 (ru) * 2003-09-17 2009-02-10 Янссен Фармацевтика Н.В. Конденсированные гетероциклические соединения
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
JP4816453B2 (ja) * 2004-04-12 2011-11-16 大正製薬株式会社 環状アミン化合物
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
FR2885905A1 (fr) * 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
WO2007009485A1 (en) * 2005-07-22 2007-01-25 Pharma C S.A. Substituted 8-phenoxy-y-carboline derivatives with 5ht1 activity
WO2007058580A1 (en) * 2005-11-15 2007-05-24 Astrazeneca Ab Novel 2-aminopyrimidinone derivatives and their use
US20080083807A1 (en) * 2006-10-06 2008-04-10 Beardsley John W Surgical instrument including a locking assembly
AU2008302751A1 (en) * 2007-09-20 2009-03-26 D2E, Llc Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use
EP2236511A4 (en) 2007-12-21 2011-04-13 Alla Chem Llc LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF
RU2374245C1 (ru) 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
CN105399674B (zh) 2015-12-31 2017-02-15 青岛清原化合物有限公司 吡唑类化合物或其盐、制备方法、除草剂组合物及用途
CN106631941B (zh) * 2016-12-30 2018-09-28 青岛瀚生生物科技股份有限公司 一种2-甲基-3氯苯基甲硫醚的制备方法
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
CN110698474B (zh) * 2019-11-14 2021-11-02 福州大学 一种α位取代四氢-γ-咔啉类化合物及其制备方法和应用
US20230339949A1 (en) * 2020-10-09 2023-10-26 Shujing Biopharma Co., Ltd HETEROCYCLIC SUBSTITUTED FUSED y-CARBOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410286C2 (de) * 1984-03-21 1986-01-23 Fresenius AG, 6380 Bad Homburg Verfahren zur Trennung von Blut sowie Vorrichtung zur Durchführung des Verfahrens
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
RU2067980C1 (ru) * 1992-06-30 1996-10-20 Глэксо Груп Лимитед Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты
ES2204932T3 (es) * 1994-09-12 2004-05-01 Eli Lilly And Company Limited Moduladores serotonergicos.

Also Published As

Publication number Publication date
AU752410B2 (en) 2002-09-19
DE69815700D1 (en) 2003-07-24
PL191863B1 (pl) 2006-07-31
PL339143A1 (en) 2000-12-04
TW531539B (en) 2003-05-11
RU2208614C2 (ru) 2003-07-20
CZ2000726A3 (cs) 2000-07-12
KR100603896B1 (ko) 2006-07-25
IL134894A (en) 2005-03-20
CA2301807A1 (en) 1999-03-18
CN1269800A (zh) 2000-10-11
EP0905136A1 (en) 1999-03-31
ES2202902T3 (es) 2004-04-01
NO20000737D0 (no) 2000-02-14
SK2992000A3 (en) 2001-03-12
DE69815700T2 (de) 2004-04-29
NO20000737L (no) 2000-05-08
CN1110496C (zh) 2003-06-04
JP2001515899A (ja) 2001-09-25
AU9742198A (en) 1999-03-29
TR200000616T2 (tr) 2000-07-21
WO1999012926A1 (en) 1999-03-18
US20020103209A1 (en) 2002-08-01
CZ297220B6 (cs) 2006-10-11
ID23954A (id) 2000-06-08
EP1015451A1 (en) 2000-07-05
SK285594B6 (sk) 2007-04-05
BR9811769A (pt) 2000-08-29
US6506768B2 (en) 2003-01-14
ZA988161B (en) 2000-03-22
HRP20000108A2 (en) 2000-12-31
HK1029107A1 (en) 2001-03-23
KR20010022391A (ko) 2001-03-15
US6303614B1 (en) 2001-10-16
NO315236B1 (no) 2003-08-04
EE200000059A (et) 2000-10-16
ATE243209T1 (de) 2003-07-15
HUP0003577A3 (en) 2003-05-28
NZ503096A (en) 2001-11-30
MY129176A (en) 2007-03-30
HUP0003577A2 (hu) 2001-09-28
EP1015451B1 (en) 2003-06-18
IL134894A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
ID23954A (id) Tetrahidrogama-karbolin
MXPA03011244A (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6.
DE3762618D1 (de) Amidderivate.
ATE104971T1 (de) 2-aminopyrimidinon-derivate.
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
EP0430201A3 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
IL86725A (en) 1-alkyl-n-cycloalkyl- 6-methyl-ergoline-8'- carboxamides, their preparation and pharmaceutical compositions containing them
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
ATE234086T1 (de) Creatine derivate für asthma
ATE169015T1 (de) Aminobenzoesäure derivate
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
IL99434A0 (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and pharmaceutical compositions containing them
BG105521A (en) Benzisoxazoles and phenons as alpha2-antagonists
DE68923231D1 (de) Antihypertensive 3-Piperidinylindazol-Derivate.
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
DE3783821D1 (de) Tetracyclische indolderivate.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20070901